We also showed that higher levels of METTL14, miR‐6769b‐3p, and miR‐499a‐3p predicted a better prognosis, but the elevated expression of SLC2A3 and PGAM1 exhibited robustly shorter OS in patients with p53‐WT CRC (Fig 6F and Appendix Fig S8A). This evidence concerns the gene METTL14 and colorectal carcinoma.